HomeCompareEXN vs MRK

EXN vs MRK: Dividend Comparison 2026

EXN yields 677.97% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EXN wins by $698060.90M in total portfolio value
10 years
EXN
EXN
● Live price
677.97%
Share price
$0.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$698060.95M
Annual income
$541,067,584,452.82
Full EXN calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — EXN vs MRK

📍 EXN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEXNMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EXN + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EXN pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXN
Annual income on $10K today (after 15% tax)
$57,627.12/yr
After 10yr DRIP, annual income (after tax)
$459,907,446,784.90/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, EXN beats the other by $459,907,438,456.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXN + MRK for your $10,000?

EXN: 50%MRK: 50%
100% MRK50/50100% EXN
Portfolio after 10yr
$349030.51M
Annual income
$270,533,797,125.48/yr
Blended yield
77.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EXN
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXN buys
0
MRK buys
0
No recent congressional trades found for EXN or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEXNMRK
Forward yield677.97%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$698060.95M$56.8K
Annual income after 10y$541,067,584,452.82$9,798.13
Total dividends collected$685272.60M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EXN vs MRK ($10,000, DRIP)

YearEXN PortfolioEXN Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$78,497$67,796.61$11,206$366.19+$67.3KEXN
2$581,356$497,364.87$12,650$502.35+$568.7KEXN
3$4,064,621$3,442,569.86$14,407$694.19+$4.05MEXN
4$26,843,663$22,494,518.82$16,585$967.82+$26.83MEXN
5$167,562,735$138,840,015.15$19,342$1,363.89+$167.54MEXN
6$989,257,646$809,965,519.98$22,913$1,947.19+$989.23MEXN
7$5,527,550,699$4,469,045,016.92$27,662$2,823.89+$5527.52MEXN
8$29,251,975,998$23,337,496,750.85$34,159$4,173.35+$29251.94MEXN
9$146,722,776,064$115,423,161,745.79$43,337$6,308.80+$146722.73MEXN
10$698,060,954,841$541,067,584,452.82$56,776$9,798.13+$698060.90MEXN

EXN vs MRK: Complete Analysis 2026

EXNStock

Excellon Resources Inc., a silver mining and exploration company, acquires, explores, develops, and exploits mineral properties in Mexico and Canada. The company primarily explores for silver, lead, zinc, and gold deposits. It holds 100% interests in the Platosa property covering an area of approximately 11,000 hectares located in Durango State, Mexico; the Evolución property that covers an area of 45,000 hectares situated in the states of Durango and Zacatecas, Mexico; and the Silver City Project totaling an area of 164 square kilometers in Saxony, Germany. It also holds 100% interests in the Kilgore Project that covers an area of 6,788 located in Clark County, Southeastern Idaho; and the Oakley Project covering an area of 2,833 hectares in Oakley, Idaho. The company was incorporated in 1987 and is based in Toronto, Canada.

Full EXN Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EXN vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXN vs SCHDEXN vs JEPIEXN vs OEXN vs KOEXN vs MAINEXN vs JNJEXN vs ABBVEXN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.